Serum bilirubin levels and mortality after myeloablative allogeneic hematopoietic cell transplantation.

Gooley, Ted A; Rajvanshi, Pankaj; Schoch, H Gary; McDonald, George B

Gooley, Ted A; Rajvanshi, Pankaj; Schoch, H Gary; McDonald, George B.

Affiliation

Gooley TA; Section of Clinical Statistics, Clinical Research Division, Fred Hutchinson Cancer Research Center, and the University of Washington School of Medicine, Seattle, WA 98109-1024, USA.

Hepatology ; 41(2): 345-52, 2005 Feb.

Article in En | MEDLINE | ID: mdl-15660388

Subject(s)

Bilirubin/blood; Hematopoietic Stem Cell Transplantation/mortality; Myeloablative Agonists/therapeutic use; Adolescent; Adult; Aged; Child; Child, Preschool; Cohort Studies; Female; Humans; Hyperbilirubinemia/physiopathology; Infant; Jaundice/blood; Jaundice/complications; Jaundice/mortality; Male; Middle Aged; Multiple Organ Failure/etiology; Platelet Count; Proportional Hazards Models; Severity of Illness Index; Time Factors; Transplantation, Homologous

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Bilirubin / Hematopoietic Stem Cell Transplantation / Myeloablative Agonists Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Language: En Journal: Hepatology Year: 2005 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links